BioCentury | Jun 7, 2019
Targets & Mechanisms

Following PARP, ATR axis next in line to expand synthetic lethal drug class

...AstraZeneca has AZD1390 in Phase I testing for brain cancer. Merck KGaA has M-3541 and Shuttle Pharmaceuticals Inc....
BioCentury | Jan 13, 2018
Finance

Choosy investors

...Ltd. (TPEx-E:6453) 3/3/17 TBD Ph III Iaso BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....
BioCentury | Oct 6, 2017
Finance

High as a Kite

...TPEx-E:6453) (D) 3/3/17 TBD Ph III Iaso BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....
BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

...NASDAQ:BIIB); GV; Hatteras Venture Partners; Johnson & Johnson Development Corp.; Remeditex Ventures; Third Point Ventures Shuttle Pharmaceuticals Inc....
BioCentury | Jul 7, 2017
Finance

Generalists needed

...TPEx-E:6453) (D) 3/3/17 TBD Ph III Iaso BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....
BioCentury | Apr 7, 2017
Finance

Taking notice

...1/4/17 TBD Mkt (tools & services) Iaso Biomed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....
BioCentury | Jan 6, 2017
Finance

Good riddance

...12/30/16 Up to $86.3M Ph II Iaso Biomed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....
BioCentury | Dec 16, 2016
Financial News

Shuttle Pharmaceuticals proposes IPO

...at $8 in a self-underwritten, best efforts IPO on NYSE MKT. Shuttle Pharmaceuticals Inc. , Rockville, Md. Alicia Parker Shuttle Pharmaceuticals Inc....
Items per page:
1 - 8 of 8
BioCentury | Jun 7, 2019
Targets & Mechanisms

Following PARP, ATR axis next in line to expand synthetic lethal drug class

...AstraZeneca has AZD1390 in Phase I testing for brain cancer. Merck KGaA has M-3541 and Shuttle Pharmaceuticals Inc....
BioCentury | Jan 13, 2018
Finance

Choosy investors

...Ltd. (TPEx-E:6453) 3/3/17 TBD Ph III Iaso BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....
BioCentury | Oct 6, 2017
Finance

High as a Kite

...TPEx-E:6453) (D) 3/3/17 TBD Ph III Iaso BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....
BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

...NASDAQ:BIIB); GV; Hatteras Venture Partners; Johnson & Johnson Development Corp.; Remeditex Ventures; Third Point Ventures Shuttle Pharmaceuticals Inc....
BioCentury | Jul 7, 2017
Finance

Generalists needed

...TPEx-E:6453) (D) 3/3/17 TBD Ph III Iaso BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....
BioCentury | Apr 7, 2017
Finance

Taking notice

...1/4/17 TBD Mkt (tools & services) Iaso Biomed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....
BioCentury | Jan 6, 2017
Finance

Good riddance

...12/30/16 Up to $86.3M Ph II Iaso Biomed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....
BioCentury | Dec 16, 2016
Financial News

Shuttle Pharmaceuticals proposes IPO

...at $8 in a self-underwritten, best efforts IPO on NYSE MKT. Shuttle Pharmaceuticals Inc. , Rockville, Md. Alicia Parker Shuttle Pharmaceuticals Inc....
Items per page:
1 - 8 of 8